Department of Urology and Renal Transplant, Kasturba Medical College, Manipal, Manipal Academy of Higher Education, Manipal, India.
Department of Urology, Istanbul Medipol University, İstanbul, Turkey.
World J Urol. 2024 Oct 3;42(1):556. doi: 10.1007/s00345-024-05228-2.
The study assesses the decisional regret following Shared Decision-making (SDM) in patients selecting either early ureteroscopic lithotripsy (URSL) or medical expulsive therapy (MET) for ureteric stones ≤ 1 cm, with the aim to evaluate their decisional Conflict, satisfaction, and regret regarding their opted treatment choices.
Adults aged more than 18 years with one stone up to 1 cm in either ureter were included. After SDM, the patients were allocated into their opted group viz. URSL or MET. Patients in each group were reassessed at "treatment completion". Cambridge Ureteric Stone PROM (CUSP) questionnaire for HRQoL, Decision Regret Scale and the OPTION scale (SDM) were filled at treatment completion.
111 patients opted for MET, while 396 patients opted for early URSL. Mean stone size was larger in URSL group (7.16 ± 1.63 mm vs. 5.50 ± 1.89; p < 0.001). Decisional conflict was higher in patients opting for URSL (77.3% vs. 57.7%; p < 0.001). Stone-free rate at four weeks was higher in URSL group (87.1%vs68.5%, p < 0.001). Decisional regret was higher in patients opting for MET (33.24 ± 30.89 vs. 17.26 ± 12.92; p = 0.002). Anxiety, was higher in patients opting for MET (6.94 ± 1.89 vs. 5.85 ± 1.54; p < 0.001). Urinary symptoms and interference in patients' travel plans and work-related activities were more in URSL group (6.21 ± 1.57 vs. 5.59 ± 1.46; p < 0.001 and 6.56 ± 1.59 vs. 6.05 ± 1.72; p < 0.001 respectively).
After SDM, decisional regret is higher in patients opting for MET mainly due protracted treatment duration with increased pain and anxiety during the treatment course and the need for additional procedure for attaining stone clearance and the. Despite higher decisional conflict, a larger proportion of patients opt for early URSL with the aim of avoiding anxiety and achieving early stone clearance.
本研究评估了在选择早期输尿管镜碎石术(URSL)或药物排石治疗(MET)治疗输尿管结石≤1cm 的患者中,通过共同决策(SDM)后出现的决策后悔情况,目的是评估他们对所选治疗方案的决策冲突、满意度和后悔程度。
纳入年龄超过 18 岁且单侧输尿管内有 1 颗结石,大小为 1cm 以内的患者。SDM 后,患者根据选择的治疗方法被分为 URSL 组或 MET 组。每组患者在“治疗结束”时再次进行评估。采用剑桥输尿管结石患者健康相关生活质量问卷(CUSP)、决策后悔量表和 OPTION 量表(SDM)评估治疗结束时的生活质量、决策后悔和治疗选择。
111 例患者选择 MET,396 例患者选择早期 URSL。URSL 组的结石平均大小较大(7.16±1.63mm 比 5.50±1.89mm;p<0.001)。选择 URSL 的患者决策冲突更高(77.3%比 57.7%;p<0.001)。4 周时 URSL 组的结石清除率更高(87.1%比 68.5%;p<0.001)。选择 MET 的患者决策后悔更高(33.24±30.89 比 17.26±12.92;p=0.002)。选择 MET 的患者焦虑更高(6.94±1.89 比 5.85±1.54;p<0.001)。URSL 组的尿路症状和对旅行计划及工作相关活动的干扰更多(6.21±1.57 比 5.59±1.46;p<0.001 和 6.56±1.59 比 6.05±1.72;p<0.001)。
SDM 后,选择 MET 的患者决策后悔更高,主要是因为治疗时间延长,治疗过程中疼痛和焦虑增加,需要额外的治疗来清除结石。尽管决策冲突更大,但更多的患者选择早期 URSL,目的是避免焦虑并尽早清除结石。